Friday, 10 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Why Viking Therapeutics could be ‘onto something pretty amazing’
Economy

Why Viking Therapeutics could be ‘onto something pretty amazing’

Last updated: August 25, 2024 7:51 pm
Share
Why Viking Therapeutics could be ‘onto something pretty amazing’
SHARE

Eli Lilly (LLY) and Novo Nordisk (NVO) have seen a surge in their stock prices over the past year, thanks to the success of their blockbuster GLP-1 drugs for treating obesity. Both companies have experienced significant growth, with Lilly’s shares up 72% and Novo’s up 44%. Novo Nordisk is currently the largest company in Europe by market cap, while Lilly ranks eighth among US companies with a market cap of $900 billion.

Investors have been drawn to these companies due to promising research that suggests expanded indications for their drugs beyond weight loss and diabetes treatment. This has led investors to search for the next big breakthrough in the space, with many eyeing Viking Therapeutics (VKTX) as a potential contender.

RSE Ventures CEO Matt Higgins recently made the case for Viking Therapeutics on a segment of Good Buy or Goodbye, highlighting the company’s innovative approach to developing GLP-1 drugs. Viking is working on two products – a monthly injection and a pill – that have shown promising results in early studies. This has led to a nearly 250% increase in Viking’s stock price this year, despite the company not yet generating any revenue.

One of the key appeals of Viking Therapeutics is its potential for acquisition, with Higgins estimating a takeout value of $15 billion, double its current market cap. Additionally, the company is expected to provide updates on its GLP-1 research at a conference in November, which could serve as a catalyst for further growth.

Despite its smaller size and lack of revenue, Higgins believes that Viking Therapeutics still has room for growth, with potential for significant upside in the future. As investors continue to search for the next big player in the obesity treatment market, Viking Therapeutics remains a top contender to watch.

See also  Analysis-US sanctions could cause chaos on Latam farms run on Russian fertilizers

In conclusion, the success of Eli Lilly and Novo Nordisk in the GLP-1 space has paved the way for smaller players like Viking Therapeutics to make a name for themselves. With promising research and potential for acquisition, Viking Therapeutics is poised for future growth and could be the next hot stock in the obesity treatment market.

TAGGED:amazingprettyTherapeuticsViking
Share This Article
Twitter Email Copy Link Print
Previous Article Dividend stocks play a big role in the decline due to the Fed and interest rates Dividend stocks play a big role in the decline due to the Fed and interest rates
Next Article Highlights of My Weekly Reading, August 25, 2024 Highlights of My Weekly Reading, August 25, 2024
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Ice roads are a lifeline for First Nations. As Canada warms, they’re disappearing.

The region holds an estimated $60 billion in minerals, including gold, copper, and nickel. But…

May 15, 2025

These Luxe-Looking Tops Are the Key to Dressing Rich This Spring

When it comes to shopping for spring and summer tops, it can be a challenge…

April 29, 2025

Rihanna Gives Birth, Welcomes 3rd Baby With ASAP Rocky

Rihanna and ASAP Rocky have officially expanded their family, joyously announcing the arrival of their…

September 25, 2025

Migrant gets 4 years for mugging 80-year-old, burglarizing a home while on pretrial release

Venezuelan Migrant Sentenced to Four Years in Prison for Robbery and Burglary A Venezuelan migrant,…

August 3, 2025

Earn an Extra $100 Before Bed With These 6 Nightly Side Gigs

In today's economic climate, saving money can feel like an impossible task. With the rising…

April 20, 2025

You Might Also Like

Should You Buy Novartis Stock Before October 28?
Economy

Should You Buy Novartis Stock Before October 28?

October 10, 2025
I’m a Financial Advisor: People Always Regret Doing These 5 Things With Their Roth IRA
Economy

I’m a Financial Advisor: People Always Regret Doing These 5 Things With Their Roth IRA

October 10, 2025
This Analyst Just Hiked Their UnitedHealth Stock Price Target by 50%. Should You Buy UNH Now?
Economy

This Analyst Just Hiked Their UnitedHealth Stock Price Target by 50%. Should You Buy UNH Now?

October 10, 2025
Why Is Wolfspeed Stock Soaring Today?
Economy

Why Is Wolfspeed Stock Soaring Today?

October 10, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?